Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vicinitas Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Vicinitas Therapeutics

Vicinitas Therapeutics

Series A

San Francisco-based Vicinitas Therapeutics, a biotech startup, develops impactful medicines using its proprietary DUBTAC platform.

HQ
San Francisco, CA, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Vicinitas Therapeutics, founded in San Francisco, California, is a biotech startup dedicated to developing transformative medicines. The company's core mission is to leverage its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease, thereby providing therapeutic benefits. Vicinitas focuses on creating next-generation treatments that significantly impact patient lives.

Notable figures affiliated with Vicinitas Therapeutics include leading scientists and industry experts, although specific names are not provided. The company has attracted significant attention from investors in the biotech sector due to its innovative approach and potential for high-impact therapies. Vicinitas's key achievements include advancing its DUBTAC platform and making strides in drug development, positioning itself as a promising player in the biotech industry.

Vicinitas Therapeutics - Similar Companies

Entact Bio logo

Entact Bio

entactbio.com

Vetica Labs logo

Vetica Labs

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Juvena Therapeutics logo

Juvena Therapeutics

Vevo Therapeutics logo

Vevo Therapeutics

vevo.ai

Montara Therapeutics logo

Montara Therapeutics

Vibe Bio logo

Vibe Bio

vibebio.com

Enlaza Therapeutics logo

Enlaza Therapeutics

Neomorph logo

Neomorph

neomorph.com

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Viscient Bio logo

Viscient Bio

Vivace Therapeutics logo

Vivace Therapeutics

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Nurix logo

Nurix

nurixtx.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Vicinitas Therapeutics - Quick Facts

Who are Vicinitas Therapeutics' competitors?

Companies similar to Vicinitas Therapeutics include Entact Bio, Vetica Labs, Deep Apple Therapeutics and Juvena Therapeutics.

When was Vicinitas Therapeutics founded?

Vicinitas Therapeutics was founded in 2022.

Where is Vicinitas Therapeutics' headquarters located?

Vicinitas Therapeutics' headquarters is located in San Francisco, CA, US.

When was Vicinitas Therapeutics' last funding round?

Vicinitas Therapeutics' most recent funding round was for $65M (USD) in July 2022.

How much has Vicinitas Therapeutics raised to-date?

As of Jul 28, 2022, Vicinitas Therapeutics has raised a total of $65M (USD).

How many employees does Vicinitas Therapeutics have?

Vicinitas Therapeutics has 23 employees as of Feb 4, 2024.

Vicinitas Therapeutics - Classification

Ownership
  • Venture Capital
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotech
  • Therapeutics
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified